Sakuraba, Hitoshi <br/><br/>
Plasma lyso-Gb3: a biomarker for monitoring fabry patients during enzyme replacement therapy.  [electronic resource] 

 -  Clinical and experimental nephrology  Aug 2018 
 - 843-849 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1437-7799 
<br/><br/><label>Standard No.: </label>10.1007/s10157-017-1525-3  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Biomarkers--blood<br/>Enzyme Replacement Therapy<br/>Fabry Disease--drug therapy<br/>Female<br/>Glycolipids--blood<br/>Humans<br/>Male<br/>Sphingolipids--blood<br/>alpha-Galactosidase